GlucoTab® Version 8.1 (August 2022)

The big news of GlucoTab version 8.1 in August 2022 was the GlucoTab App for cobas® pulse, the new blood glucose meter for hospitals from Roche Diagnostics.

As of 11/22/2022, the GlucoTab app for cobas pulse is now officially approved for the platform and available on it.

The native Android app has been customized for the display and the specific requirements of cobas pulse.

The main functions used by nurses in diabetes management are fully available:

  • Login/logout
  • Patient list / task overview
  • Patient main screen with blood glucose and therapy profile and buttons for open tasks
  • Display ordered therapy and prior therapy
  • Initiate BG measurement using the cobas pulse Glucose App
  • Enter BG measurements manually
  • Medication administration with display of dose suggestions
    • entering meal yes/no if necessary
    • changing the suggested medication dose possible
    • entering physician for verbal order
  • Dispensing oral medication / Cancel already documented dispensations
  • Adjustment of dispensation when an already dispensed medication order was changed
  • Therapy/dose adjustment in algorithm supported therapy
  • View/Edit/Delete already performed activities in therapy profile
  • Add/Edit/Delete free text comments in therapy plan

Patient enrollment as well as adding and editing prescriptions in Custom Therapy are primarily physician functions and are not (yet) available on cobas pulse.

GlucoTab® Version 8.0 (February 2022)

New feature: Documentation intravenous insulin infusion with infusion pump

  • New therapy type for documentation of intravenous insulin infusion with infusion pump
    • Preparation of the infusion
    • Specification of a blood glucose measurement frequency every x minutes
    • Scheme for proposed flow rate as a function of blood glucose that can be predefined
    • Continuous documentation of the flow rate with presentation in the course of therapy chart
  • Changes in relation to i.v. insulin therapy
    • Better differentiation between the display of i.v. and s.c. insulin. insulin prescriptions in the therapy plan
    • The filter function in the drug selection dialogue is now dependent on s.c. or i.v. administration (insulin pen not for i.v., vial not for s.c.).

New: Availability of insulin degludec (Tresiba®, Novo Nordisk®) in GlucoTab Algorithm supported therapy

User Interface Improvements

  • Fundamental reorganisation of the user interface so that the therapy course (chart with blood glucose and documented activities) and therapy plan (order) are aligned exactly on top of each other with the same time axis + technical realisation with new charting library.
  • Possibility of configuring that drug doses or measured values are indicated to two decimal places.
  • The ward abbreviations of the hospital information system are not understandable for users. A configurable mapping 1:1 or 1:n, also with wildcards, to human readable ward names was introduced.
  • The fields displayed in the main patient view for patient identification are now configurable: Date of birth, PID, national insurance number

Improvements short acting insulin and supplement schemes

  • When prescribing short-acting insulin, it is now possible to specify whether it should only be administered if the patient eats a meal.
  • Extension of the functionality for supplement schemes by
    • the reduction of meal insulin for low blood glucose levels
    • Alternative correction scheme for the period bedtime/night (reduction of the correction dose of the day by x%)
  • If the blood glucose value for the dose calculation according to the correction scheme is above the upper limit of the correction scheme, then a configurable message is displayed when the medication is administered, e.g. “Information to pysician on duty after administration of correction insulin”.

Extended functionality gestational diabetes

  • Gestational diabetes is now available for documentation as additional diabetes type in the list (Until now “other diabetes type” was used also for patients with gestational diabetes). When gestational diabetes is selected, the “patient is pregnant” checkbox is automatically activated.
  • For patients with gestational diabetes, configurable target ranges for postprandial measurements can be defined, e.g. after 1h pp: 140 – 180 mg/dl, after 2h pp: 120 – 160 mg/dl

Extended functionality for hypo- or hyperglycaemia

  • Generation of a task for a control measurement also for high blood glucose values (configurable threshold) for all patients.
    Correct consideration when prescribing a correction scheme by which a control measurement is also generated for high blood glucose values.
  • When a hypo- or hyperglycaemic BG value is measured, a task with configurable validity (e.g. 1h) is created and displayed in the task list and on the patient’s main screen. Clicking on the icon opens a dialogue that explains the general procedure and optionally provides a link to an internal guideline (PDF or HTML).

Extended features at therapy start

  • It is now possible to configure that GlucoTab basal-bolus therapy can be started by nurses, when the name of the delegating physician is documented.
  • Improved use of existing information on therapy to calculate the dose suggestion for the initial insulin daily dose in basal bolus therapy: The number of insulin units from prior therapy at home and/or current inpatient therapy is now also automatically determined.
  • Allow the user to take over the last known inpatient therapy from a previous enrolment.

Documentation discharge therapy

  • The previous therapy as well as the currently prescribed therapy can be output as a copyable character string in the text fields for the discharge therapy in order to take them over with copy & paste, e.g. in a discharge letter.

Improved wording and consistency

  • Consistent function and display of the “Confirm”, “Save” or “Close” buttons
  • Display of an explanation for dose entry with the keyboard in the drug prescription dialogue
  • Mandatory setting of the start date when taking over a drug from the previous therapy with an administration frequency > 1 day
  • Warning messages now better explain that total daily dose adjustment needs to be performed that the algorithm can calculate a dose suggestion (when the basal-bolus algorithm is in pending mode and medication administration is started).
  • The error message “please contact technical support” can now be replaced by a customer-specific (configurable) string to allow more actionable information for users in case of a problem, e.g.: “Please write a support ticket to …”
  • Improved wording in notification in Basal Only when new basal dose cannot be calculated due to missing bg measurements

Improvements integration: drug catalogue, organizational structure

  • Incremental updates of the medication list now allow for frequent (daily) updates. In doing so, avoid as much as possible the situation where medication orders may no longer be edited after the update BUT recognize critical changes.
  • Possibility of user assignment to one or more wards via ActiveDirectory roles and corresponding adjustment of the GlucoTab Launcher, close the Launcher window when logging out.
  • When opening the patient list without a ward being selected: Allow selection of a ward instead of loading of all wards.


  • Task generation for medication administration of a backdated task is now handled correctly

GlucoTab® version 7.1.1 (July 2021)

The first GlucoTab version which is certified under the new European Medical Device Regulation (MDR) as a Class IIa medical device was released on July 6th, 2022.

GlucoTab® version 7.1 (December 2020)

  • Displaying or filtering available and unavailable medications in the facility.
    • The list for selecting drugs now additionally shows whether a drug is available or not.
    • There is also an additional filter function to show only available drugs in the list. For pre-therapy and self-management, all drugs are listed by default, for inpatient therapy only the available drugs are displayed.
  • Electronic version of the user manual
    • In addition to the printed version of the user manual, with version 7.1 it is possible to access an electronic version of the user manual directly from GlucoTab.
  • After importing a hypoglycemic blood glucose value, a task for a control measurement is now automatically created. This automatism was previously only provided after manual entry with a confirmation dialog.
  • Stopping a patient’s enrollment by a nurse now requires a verbal order from a physician when the patient has prescribed therapy.
  • An additional user manual for operation (technical manual) has been prepared.

GlucoTab® version 7.0 (August 2020)

  • Additional therapy algorithm for basal insulin therapy (BOT/BIT)
    • GlucoTab thus provides algorithm support for two types of therapy: GlucoTab basal bolus therapy and new: GlucoTab basal insulin therapy (BOT/BIT: basal insulin-assisted oral or incretin therapy).
    • On the one hand, this therapy regimen is designed for geriatric persons with diabetes, whose blood sugar target values can be set depending on their health status. For people with diabetes, e.g. after newly initiated insulin therapy, basal insulin therapy may also be sufficient.
    • The blood glucose target range and the frequency of insulin titration are determined individually depending on the patient’s health status.
    • Blood glucose control is mainly achieved with a once-daily long-acting basal insulin (optionally in combination with oral antidiabetic drugs or incretins). Correction with short-acting supplemental insulin is only carried out in case of very high blood glucose levels.
    • To avoid a blood glucose increase during the day, bolus insulin can be prescribed once a day in the morning or with the largest meal – basal insulin plus (BOT+/BIT+) therapy.
  • Different task types to reactivate decision support
    • Regular therapy adjustment with one of the two GlucoTab therapy algorithms may be performed by physicians and nurses (in role “nurse+”)
    • However, certain situations require a therapy evaluation, which must be carried out by a physician.
    • For therapy adjustment and therapy evaluation, different task types are now distinguished, and different symbols are displayed.
  • Also when using a GlucoTab therapy algorithm (basal-bolus or basal insulin BOT/BIT therapy), free text comments on basal insulin or bolus insulin can now be entered, which are displayed to the nurse during medication administration.
  • If, during medication administration, the suggested/displayed dose has been increased or decreased by the user, this adjustment is visualized in the therapy profile by arrows next to the administered dose. This makes it easier to see if the medication was administered as planned. Backdated drug administration is also highlighted.
  • If significantly less or more insulin has been administered to a patient in GlucoTab basal bolus therapy since the last dose adjustment than was suggested by the system (i.e. if the suggested dose was always changed manually when administering the medication), then the daily insulin dose is not increased or reduced during therapy adjustment, even if blood glucose target values were not reached. The user is informed about this in a dialogue.
    This safety measure may be relevant if nurses are very cautious and administer less insulin than the system suggests. This prevents the prescribed insulin dose from being increased even though more insulin has already been prescribed than was administered to the patient (and vice versa).
  • In addition to the pre-therapy, there is now also the possibility of planning a discharge therapy. A plan (possibly also for accompanying measures such as patient education) or a specific therapy for the discharge of the patient can be documented in a free text field.
  • Further improvements:
    • When a basal insulin administration is suggested for the first time after starting an algorithm-assisted therapy, the system will advise that previous insulin doses may still be active, and the suggested dose may need to be reduced manually. (Basal insulin or premixed insulin administered before the start of therapy are not known and must therefore be considered manually).
    • The manual entry of a blood glucose measurement can now also be confirmed with the Enter key on the keyboard. The enter key must be pressed twice. First the entry is checked for correctness and completeness, and the second time the entry is saved.
    • An additional diabetes type “undiagnosed diabetes” can be selected during enrolment if blood glucose measurements are performed on the patient – for observation only.
    • Comments can now be added or edited also for blood glucose measurements performed with POCT or via the laboratory. If comments from the laboratory are available, they are displayed in a separate field in the measurement details
    • The list with verbal orders is now visible also for nurses. Acknowledgement of verbal orders must still be done by physicians.

GlucoTab® version 6.1 (January 2020)

  • Easier selection of the main functions with highlighting of open tasks:
    The buttons for selecting the GlucoTab main actions have been merged with the display of open tasks. It is therefore now possible to click directly on the icon of the open task to perform it.
  • Enhanced support for dispensing oral medication
    • When the order of an already dispensed oral drug is changed, GlucoTab generates a task to correct the dispensed dose by adding or removing tablets in the dispenser.
    • A new task type has been created for these “dispenser adjustment” tasks.
    • A symbol in the therapy plan indicates that the prescription has been changed after dispensing.
    • Tasks for the administration of single orders no longer have their own task type. The “medication administration” task is now the same for all prescriptions.
  • Warning of unsaved changes:
    If a therapy adjustment or medication administration was started but not finished (e.g. because the application was closed without saving), the next time the patient is edited, a warning is displayed and a suggestion is made to contact the displayed user.
  • Improved self-management mode:
    • Therapy start: “Self-management” is now available as a therapy type. In this case, the pre-therapy is always taken over into the current therapy.
    • During medication administration, no dose is preset, but an undetermined dose (X or *) is shown for each medication. The fixed ordered dose or the dose determined according to dose calculation by the system can be displayed additionally and used as support for the patient.
  • Changes at therapy start
    • The selection “Currently no inpatient therapy” for the therapy type is only available for outpatients to indicate that the therapy was only recorded in the course of a preparatory examination.
    • A type of diabetes entered by the nursing staff is listed as “preliminary” until the initial therapy order has been carried out by a physician
  • Improvements for single orders / verbal orders
    • When a nurse enters a verbal order for a single administration, which can immediately be administered, the system automatically allows to also confirm the medication administration.
    • A warning is now displayed when certain oral drugs such as sulfonylurea are added as a single order
    • It is now possible to configure the default value for the time interval, new single orders should be in the future (e.g. administration time is set to 10 minutes in the future by default for new single orders)
  • Improvements for orders with undetermined dose (X-dose or *-dose)
    • If an undetermined (X) dose is ordered for an oral drug in an interval order for a time of day, the X order is now also presented in the medication administration to easily allow entering a verbal order of the dose to administer
    • When an undetermined (X) dose is ordered for a time of day, the system now always generates a blood glucose measurement task, regardless of whether a measurement is ordered
    • When a dose was determined for an X-order in the current time of day, no insulin-on-board calculation is performed, because it is assumed that all factors influencing the dose were already considered by the physician.
  • Therapy plan improvements
    • The option to start a therapy adjustment is now displayed in the context menu in read-only mode, to make it easily accessible
    • The bracketed form is now also used for oral medications, e.g. if a medication was not taken as prescribed: 0 [1].
    • A legend with the description of the configured bracket notation, e.g. “Administered dose [originally planned dose]” is now displayed under the therapy plan
    • The day of the week is now also displayed for the dates in the therapy plan.
    • When using the insulin bolus calculator, the order (unit IE/BE) and the administered dose (unit IE) are now displayed in two separate lines
  • Further functional improvements
    • Comments to laboratory values GFR or HbA1c are now displayed directly next to the laboratory value.
    • The patient lock is now removed when a user leaves GlucoTab by navigating in the integrated mode or logs out. This avoids problems with locked patients when accidentally leaving GlucoTab.
    • Alerts acknowledged by users are now logged by the system.
  • Technical improvements
    • The native Android app for tablets was replaced by a web interface optimised for mobile devices.
      This reduces the platform dependency and GlucoTab can be used in the future on mobile devices with both Android and Apple operating systems.
    • For a more flexible and easier integration, software components have been developed which can be adapted and released in a separate software development process independent of the release cycle of the medical device GlucoTab.
    • GlucoTab now uses a Java version based on OpenJDK
  • Interface to electronic medication systems
    • A deep integration was prepared by the development of data interfaces and the integration of message transmission into the work processes.
    • HL7 messages are based on IHE Hospital Medication Workflow recommendations
    • Transmission of all medication orders and medication dispensations from GlucoTab
    • Taking over the dispensing of oral medications carried out in the medication system
    • Taking over the pre-therapy

GlucoTab® version 6.0 (March 2019)

  • GlucoTab is now also approved for the documentation of the therapy of patients with type 1 diabetes.
  • Bolus calculator for intensive insulin therapy: dose calculation based on carbohydrate factor after input of carbohydrate exchange units and correction factor.
  • Basal insulin can now be administered in basal bolus therapy at different times of the day. Up to now, the administration of long-acting insulin was only intended for noon in basal bolus therapy with decision support. Now the administration can also be prescribed in the evening and before going to bed.
  • Presentation of the insulin daily dose in basal bolus therapy over time in the therapy plan during therapy adjustment
  • Support of patient self-management:
    • If patients are marked as self-management patients, prescriptions of insulin with undetermined dose (X) are proposed because the patient himself defines the dose.
    • Of course, in this case no tasks for physicians are generated for the X orders.
    • Subsequent entry of blood glucose measurements and medication administered by the patient is possible.
  • Prescription and presentation of the blood glucose measurement frequency are possible in the medication plan over time and in advance.
  • Standardization of the user interface for nurses in different roles: Menu item therapy adjustment for entering verbal one-time orders for all nurses
  • Improved presentation of prescriptions “every n days” in the medication plan
  • Uniform sorting of medications in the therapy course, in the medication plan and during medication administration
  • Display GFR value for evaluation of kidney function (patient’s most recent value available from laboratory).
  • Double blood glucose values are only displayed once in the therapy profile. (e.g. if values are recorded manually when measuring with POCT device and received via laboratory)
  • The prescribed blood glucose target range is displayed in the therapy course diagram
  • Improved display of the prescribed insulin correction scheme by mouseover in the medication plan during prescription on the PC

GlucoTab® version 5.2 (March 2018)

In this version, new features have been added to the “electronic diabetes chart” and improvements have been made for ease of use, safety and configurability of the system.

  • Dispensing of oral medication: Marking as dispensed individually per day
  • Optimized workflow for prescriptions with undetermined dose: If an undetermined dose (X) is prescribed in a time of day, the tasks for the nurses for BG measurement and medication administration become immediately visible. Only when the blood glucose value is available, the physician task for prescribing the missing dose displayed.
  • Possibility to prescribe postprandial blood glucose measurements. Automatic generation of tasks for blood glucose measurement after the preprandial measurement (e.g. at intervals of one hour).
  • Possibility of displaying verbal orders and confirmation by a physician
  • Injectable non-insulins (e.g. GLP-1 analogues) are displayed together with the insulins for subcutaneous administration.
  • Blocking mechanism to avoid simultaneous ordering and administration of drugs
  • Safety measure: correction scheme cannot be prescribed in combination with an undetermined dose
  • Display of the currently calculated dose suggestion (e.g. due to correction scheme) also for physicians during prescription
  • Display of additional details on medication administrations already performed:
    • Composition of insulin dose (dose calculation, adjustment by user)
    • for oral orders: who has ordered, who has carried out the administration
  • Improved positioning of dialogues on the PC
  • Enrolment of a patient “without inpatient treatment” e.g. for preoperative examination in the outpatient unit
  • Revision of the HL7 ADT patient interface for more flexible adaptability to specifics of implementation in the organization

GlucoTab® version 5.1 (October 2017)

In this release, various details of the documentation functionality and work process support have been improved to increase flexibility and further simplify use.

  • Backdating of medication administrations for retrospective documentation (e.g. for self-management patients) is now possible.
  • Free text comments in the therapy plan: The comments from blood sugar values and medication prescriptions are displayed for each day in the therapy plan. Furthermore, free text comments can be added and edited by all users.
  • In addition to the prescribed drug dose, also the administered dose is displayed in the medication plan.
  • Conversion of laboratory values by configuration: e.g. the HbA1c value can optionally be displayed in the “new” unit mmol/mol or the “old” unit %.
  • Extension of the patient status information transmitted to the hospital information system: Patients with insulin therapy can be highlighted.
  • Individually prescribed blood glucose measurements are visible in the therapy plan in a space-saving manner.

GlucoTab® version 5.0 (July 2017)

With this version, GlucoTab made the step to a universally usable electronic diabetes solution, integrated into the hospital information system.

  • New user interface for use on the desktop PC
  • Integration in Hospital Information Systems (HIS) – implemented in by KAGes
  • Comprehensive support of the medication workflow for all blood glucose-lowering drugs (prescription, verbal order, determination of dose at a later time, insulin correction schemes, etc.)
  • Additional data interfaces: Import of laboratory parameters, transfer of open tasks to HIS